IL85955A - A cytoplasmic antigen is attributed to human cancer An antibody that binds to that antigen, a method for diagnosing human cancer in vitro, and a distant preparation or diagnostic agent that includes - Google Patents
A cytoplasmic antigen is attributed to human cancer An antibody that binds to that antigen, a method for diagnosing human cancer in vitro, and a distant preparation or diagnostic agent that includesInfo
- Publication number
- IL85955A IL85955A IL8595588A IL8595588A IL85955A IL 85955 A IL85955 A IL 85955A IL 8595588 A IL8595588 A IL 8595588A IL 8595588 A IL8595588 A IL 8595588A IL 85955 A IL85955 A IL 85955A
- Authority
- IL
- Israel
- Prior art keywords
- antibody
- antigen
- human
- april
- diagnostic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
- C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK169987A DK169987D0 (da) | 1987-04-03 | 1987-04-03 | Human tumor-associated antigen, ca-ou1 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL85955A0 IL85955A0 (en) | 1988-09-30 |
IL85955A true IL85955A (en) | 1994-12-29 |
Family
ID=8107312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL8595588A IL85955A (en) | 1987-04-03 | 1988-04-01 | A cytoplasmic antigen is attributed to human cancer An antibody that binds to that antigen, a method for diagnosing human cancer in vitro, and a distant preparation or diagnostic agent that includes |
Country Status (14)
Country | Link |
---|---|
US (1) | US5338661A (de) |
EP (1) | EP0285173B1 (de) |
JP (1) | JPH082920B2 (de) |
KR (1) | KR890700358A (de) |
AU (1) | AU618260B2 (de) |
DE (1) | DE3884646T2 (de) |
DK (1) | DK169987D0 (de) |
ES (1) | ES2059418T3 (de) |
FI (1) | FI894650A (de) |
IE (1) | IE60993B1 (de) |
IL (1) | IL85955A (de) |
NZ (1) | NZ224156A (de) |
WO (1) | WO1988007377A1 (de) |
ZA (1) | ZA882353B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619226B2 (en) * | 1987-09-28 | 1992-01-23 | Children's Hospital Medical Center | Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods |
US5118611A (en) * | 1988-07-25 | 1992-06-02 | Adeza Biomedical Corporation | Adenocarcinoma antigen binding methods and reagents |
CA2015862A1 (en) * | 1989-05-04 | 1990-11-04 | Gajanan Nilaver | Cell surface antigen that binds with l6 monoclonal antibody |
JPH07506484A (ja) * | 1992-01-29 | 1995-07-20 | サイ−クロン,インコーポレーテッド | カルチノーマ関連抗原(sk1),sk1に対するモノクローナル抗体,これら抗体を産生する方法及びその使用 |
US5834215A (en) * | 1994-10-05 | 1998-11-10 | The Administrators Of The Tulane Educational Fund | Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS) |
US5744585A (en) * | 1995-03-16 | 1998-04-28 | Medenica; Rajko D. | Human monoclonal antibody against lung carcinoma |
US6288215B1 (en) | 1996-08-30 | 2001-09-11 | Auburn University | Monoclonal antibodies specific to cooked meats |
AU4094297A (en) | 1996-08-30 | 1998-03-19 | Auburn University | Monoclonal antibodies specific to cooked meats |
US20020127584A1 (en) * | 1997-09-18 | 2002-09-12 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU2002307494A1 (en) * | 2001-04-24 | 2002-11-05 | Bayer Corporation | Human timp-1 antibodies |
WO2003024191A2 (en) * | 2001-09-21 | 2003-03-27 | Raven Biotechnologies, Inc. | Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof |
AU2003207459A1 (en) * | 2002-01-03 | 2003-07-24 | The Scripps Research Institute | Cancer-associated epitope |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4468457A (en) * | 1981-06-01 | 1984-08-28 | David M. Goldenberg | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies |
US4579827A (en) * | 1983-03-11 | 1986-04-01 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies |
NZ210867A (en) * | 1984-01-31 | 1989-01-06 | Litton Bionetics Inc | Tumour-specific monoclonal antibodies, production thereof and use |
GR850552B (de) * | 1984-03-07 | 1985-07-05 | Du Pont | |
US4761377A (en) * | 1984-10-15 | 1988-08-02 | The Regents Of The University Of California | Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells |
ES8800604A1 (es) * | 1985-04-22 | 1987-11-16 | Hybritech Inc | Un metodo para producir anticuerpos monoclonales |
DK172686A (da) * | 1985-04-22 | 1986-10-23 | Hybritech Inc | Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet |
ATE86261T1 (de) * | 1986-04-17 | 1993-03-15 | Hybritech Inc | Tumorassoziiertes antigen. |
-
1987
- 1987-04-03 DK DK169987A patent/DK169987D0/da active IP Right Review Request
-
1988
- 1988-03-30 JP JP63503303A patent/JPH082920B2/ja not_active Expired - Lifetime
- 1988-03-30 WO PCT/DK1988/000059 patent/WO1988007377A1/en active Application Filing
- 1988-03-30 AU AU15965/88A patent/AU618260B2/en not_active Ceased
- 1988-03-30 US US07/411,469 patent/US5338661A/en not_active Expired - Fee Related
- 1988-03-31 ZA ZA882353A patent/ZA882353B/xx unknown
- 1988-03-31 IE IE97688A patent/IE60993B1/en not_active IP Right Cessation
- 1988-03-31 ES ES88105299T patent/ES2059418T3/es not_active Expired - Lifetime
- 1988-03-31 EP EP88105299A patent/EP0285173B1/de not_active Expired - Lifetime
- 1988-03-31 DE DE88105299T patent/DE3884646T2/de not_active Expired - Fee Related
- 1988-04-01 IL IL8595588A patent/IL85955A/en not_active IP Right Cessation
- 1988-04-06 NZ NZ224156A patent/NZ224156A/en unknown
- 1988-12-02 KR KR1019880701592A patent/KR890700358A/ko not_active Application Discontinuation
-
1989
- 1989-10-02 FI FI894650A patent/FI894650A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1596588A (en) | 1988-11-02 |
WO1988007377A1 (en) | 1988-10-06 |
FI894650A0 (fi) | 1989-10-02 |
DE3884646T2 (de) | 1994-01-27 |
IL85955A0 (en) | 1988-09-30 |
IE60993B1 (en) | 1994-09-07 |
EP0285173A2 (de) | 1988-10-05 |
JPH02503383A (ja) | 1990-10-18 |
IE880976L (en) | 1988-10-03 |
FI894650A (fi) | 1989-10-02 |
AU618260B2 (en) | 1991-12-19 |
KR890700358A (ko) | 1989-04-24 |
US5338661A (en) | 1994-08-16 |
EP0285173A3 (en) | 1990-01-31 |
JPH082920B2 (ja) | 1996-01-17 |
EP0285173B1 (de) | 1993-10-06 |
ES2059418T3 (es) | 1994-11-16 |
DE3884646D1 (de) | 1993-11-11 |
DK169987D0 (da) | 1987-04-03 |
NZ224156A (en) | 1991-07-26 |
ZA882353B (en) | 1988-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4446122A (en) | Purified human prostate antigen | |
JP3541296B2 (ja) | 腫瘍血管内皮細胞に特異的に結合するモノクローナル抗体とその利用方法 | |
US4708930A (en) | Monoclonal antibody to a human carcinoma tumor associated antigen | |
USRE33405E (en) | Purified human prostate antigen | |
AU612967B2 (en) | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas | |
NZ214542A (en) | Monoclonal antibodies and antigen for human non-small cell lung carcinomas | |
CA2072620C (en) | Urinary tumor associated antigen, antigenic subunits uses and methods of detection | |
EP0285173B1 (de) | Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper | |
AU677120B2 (en) | Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof | |
CA1165685A (en) | Purified prostatic tissue antigen | |
Bankert et al. | Screening and replica plating of anti-hapten hybridomas with a transfer template hemolytic spot assay | |
US5073493A (en) | Monoclonal antibody nky13 | |
JPH05506241A (ja) | 35kd腫瘍関連タンパク質抗原および免疫複合体 | |
JP4493882B2 (ja) | 抗原およびこの抗原を識別するモノクローナル抗体 | |
LV10202B (en) | Human carcinoma-associated antigen and antibody binding to the antigen | |
JPH02219594A (ja) | 肺癌に対するモノクローナル抗体および細胞表面抗原 | |
NO176903B (no) | Antistoff eller bindende fragment derav til diagnostikk av humant carcinom, eller som transportör av farmasöytiske midler, isolert, humant tumor-assosiert antigen, diagnostisk middel og fremgangsmåte for in vitro-diagnostisering | |
DK162844B (da) | Antistof mod et humant carcinom-associeret antigen, et saadant humant carcinom-associeret antigen, et anti-idiotypisk antistof rettet mod antistoffet, et anti-anti-idiotypisk antistof rettet mod det anti-idiotypiske antistof, et diagn. middel, der omfatter antistoffet eller antigenet, fremg.maade til fremstil. af et monoklonalt antistof mod et carcinom-accocieret antigen, fremg.maade til in med mere | |
JPH0630620B2 (ja) | 人体液中に存在する分子量7万〜30万のコリンエステラーゼに反応するモノクローナル抗体 | |
JPH06107695A (ja) | 新規ヒト血液細胞関連抗原及びそれを認識する単クローン抗体 | |
JPS62500699A (ja) | ヒトの癌腫瘍関連抗原に対する単クロ−ン性抗体 | |
JPH03155796A (ja) | TGF―αに対するモノクローナル抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |